## Abstract ## Background and Objectives There are many treatment modalities for psoriasis including topical therapy, ultraviolet light therapy, systemic agents, and more recently the advent of the biologic agents. ## Study Design/Materials and Methods In addition, selective treatment using lase
A Mathematical Model for Photopolymerization From a Stationary Laser Light Source
β Scribed by Michael F. Perry; Gerald W. Young
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 229 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1022-1344
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Summary: A mathematical model of photopolymerization is presented for a stationary laser. Termination by radical combination and radical trapping is considered. Using simplifying assumptions, we derive analytical equations for the concentration of photoinitiator and monomer in the system. With these equations, we show that the light intensity and the initial amount of photoinitiator highly influence the polymerization process and determine the shape of the polymer that is formed. We also provide an analytic expression to determine the amount of polymer formed during dark reactions.
Percent conversion of monomer as a function of time at zβ=β0 and rβ=β0 (Data from Table 1).
imagePercent conversion of monomer as a function of time at zβ=β0 and rβ=β0 (Data from Table 1).
π SIMILAR VOLUMES
## Abstract The derivation and experimental verification of a unified mathematical model for the estimation of drug release rate from drugβpolymer composite tablets are presented. Cylindrical coordinates are utilized in the solution of the diffusion equation for a threeβdimensional system. The mode
## Abstract Although combinatorial chemistry technology has enabled large libraries of compounds to be screened for biological activity and synthetic modifications to be effected rapidly, the reality is that quality leads and development candidates for many drug targets still prove difficult to fin
## Abstract Drugβeluting stents (DESs) are drugβdevice combination products that have been commercialized and demonstrated to be safe and efficacious in treating coronary artery disease. They have been very effective in reducing the extent of neointimal hyperplasia and therefore in preventing or mi